Expression of IL-17and IL-23 in Patients with B-cell non-HodgkinLymphoma Treated by RCHOP / 昆明医科大学学报
Journal of Kunming Medical University
; (12): 76-81, 2016.
Article
in Zh
| WPRIM
| ID: wpr-509372
Responsible library:
WPRO
ABSTRACT
Objectives To study the role of IL-17 and IL-23 in non-Hodgkin lymphoma (NHL) by detecting the expression levels of IL-17 and IL-23 in peripheral blood of B-cell non-Hodgkin lymphoma patients treated by RCHOP.Methods T wenty-five patients with B-cell NHL who achieved remission after 6 to 8 cycles of R-CHOP as a NHL group,20 healthy volunteers were recruited as a normal control group.RT-PCR was used to detect the expression levels of IL-17 mRNA and IL-23mRNA in NHL patients and health volunteers.Results The expression level of IL-17mRNA andIL-23 mRNAin the patients with NHL before therapy and the patients with NHL who achieved remission was lower than that in the normal control group (P<0.05).The expression level of IL-17mRNA andIL-23mRNA in the patients with NHL who achieved remission was higher than that in the patients with NHL before therapy (P=0.001,P<0.05).Conclusion IL-17 and IL-23mRNA expressions are higher after treated with R-CHOP.The expression levels of IL-17 mRNA and IL-23 mRNA in NHL patients are related with prognosis and efficacy.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Journal of Kunming Medical University
Year:
2016
Type:
Article